TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 4692674

Group type: EXPERIMENTAL
Intervention: Hibiscrub (4% chlorhexidine detergent solution)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dermofax (0.75% chlorhexidine detergent solution)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Disadine scrub (povidone iodine detergent preparation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hibiscrub (4% chlorhexidine detergent solution) after six applications
Number of subjects: 0

Group type: COMPARATOR
Intervention: Povidone iodine after six applications
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dermofax (0.75% chlorhexidine detergent solution) after six applications
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5% chlorhexidine digluconate in 70% ethanol (second phase of disinfection)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10% aqueous povidone iodine compresses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5% aqueous chlorhexidine digluconate compresses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chlorocresol (0.3%) liquid soap after one application
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chlorocresol (0.3%) liquid soap after six applications
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcoholic cetrimide
Number of subjects: 0

Group type: COMPARATOR
Intervention: 70% ethyl alcohol
Number of subjects: 0
Study: 30391877

Group type: EXPERIMENTAL
Intervention: Bi-cephalic transcranial Direct Current Stimulation (tDCS) with anode on PPC and cathode on Cerebellum
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bi-cephalic transcranial Direct Current Stimulation (tDCS) with cathode on PPC and anode on Cerebellum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study: 27354031

Group type: EXPERIMENTAL
Intervention: Standing cable training (SC, n = 12)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Seated machine training (SM, n = 10)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 29
Study: 24698702

Group type: EXPERIMENTAL
Intervention: Wet-wrap treatment (WWT) with diluted corticosteroids (1:3 mometasone furoate 0.1% ointment and for the face 1:19 mometasone furoate 0.1% ointment under a mask)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Emollient (petrolatum 20% in cetomacrogol cream)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wet-wrap treatment (WWT) with diluted corticosteroids
Number of subjects: 0
Study: 23588625

Group type: EXPERIMENTAL
Intervention: L-Cat intervention
Number of subjects: 267
Study: 20716244

Group type: EXPERIMENTAL
Intervention: Concomitant ibuprofen and paracetamol
Number of subjects: 1200000

Group type: COMPARATOR
Intervention: Ibuprofen alone
Number of subjects: 1200000

Group type: COMPARATOR
Intervention: Paracetamol alone
Number of subjects: 1200000
Study: 18069745

Group type: EXPERIMENTAL
Intervention: Chemotherapy added to locoregional treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized trials in patients with head and neck cancers
Number of subjects: 0
Study: 16360564

Group type: EXPERIMENTAL
Intervention: Electronic survey (tablet)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Paper survey
Number of subjects: 160

Group type: COMPARATOR
Intervention: Comparison of missing data
Number of subjects: 160
Study: 12846755

Group type: EXPERIMENTAL
Intervention: rhIGF-1 (100 mg/kg subcutaneously twice a day for 6 days)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: rhIGF-1
Number of subjects: 43
Study: 11158455

Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering dietary intervention promoting adherence to a diet with 28% of energy from total fat, <8% from saturated fat, up to 9% from polyunsaturated fat, and <75 mg/1000 kcal cholesterol per day
Number of subjects: 663

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 663
Study: 9047258

Group type: EXPERIMENTAL
Intervention: High dose chemotherapy followed by infusion of autologous hematopoietic stem cells and growth factors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard adjuvant therapies
Number of subjects: 0
Study: 7962883

Group type: EXPERIMENTAL
Intervention: Insecure case managers
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Preoccupied case managers
Number of subjects: 27

Group type: COMPARATOR
Intervention: Secure case managers
Number of subjects: 27
Study: 3036259

Group type: EXPERIMENTAL
Intervention: Clomipramine (CMI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desipramine (DMI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: m-chlorophenylpiperazine (m-CPP) 0.5 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metergoline 4 mg
Number of subjects: 0
Study: 2102029

Group type: EXPERIMENTAL
Intervention: 100 mg allopurinol + 20 mg benzbromarone
Number of subjects: 60

Group type: COMPARATOR
Intervention: 300 mg allopurinol only
Number of subjects: 60
Study: 939029

Group type: EXPERIMENTAL
Intervention: Blood pressure measurement using mercury sphygmomanometers and Physiometrics automatic recorders.
Number of subjects: 3524

Group type: EXPERIMENTAL
Intervention: Blood pressure measurement in black children.
Number of subjects: 3524

Group type: EXPERIMENTAL
Intervention: Blood pressure measurement in children in the upper five percent of pressure ranks.
Number of subjects: 3524

Group type: EXPERIMENTAL
Intervention: Stepwise multiple regression analysis of blood pressure determinants.
Number of subjects: 3524
Study: 31206593

Group type: EXPERIMENTAL
Intervention: MSB11022
Number of subjects: 443

Group type: COMPARATOR
Intervention: Reference adalimumab
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: MSB11022 after switch from reference adalimumab
Number of subjects: 443

Group type: COMPARATOR
Intervention: Reference adalimumab after switch to MSB11022
Number of subjects: 443
Study: 28898714

Group type: EXPERIMENTAL
Intervention: Continued care (CC) with weekly to monthly phone calls from a diabetes specialist nurse practitioner
Number of subjects: 151

Group type: COMPARATOR
Intervention: Usual care (UC) with follow-up by diabetes care providers
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Continued care (CC) for insulin-treated patients
Number of subjects: 151

Group type: COMPARATOR
Intervention: Usual care (UC) for insulin-treated patients
Number of subjects: 151
Study: 25728015

Group type: EXPERIMENTAL
Intervention: Perceived control
Number of subjects: 82

Group type: COMPARATOR
Intervention: No perceived control
Number of subjects: 82
Study: 23426413

Group type: EXPERIMENTAL
Intervention: Moisture subscale of the Braden Scale
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moisture subscale score groups
Number of subjects: 0
Study: 20673553

Group type: EXPERIMENTAL
Intervention: Sertindole
Number of subjects: 321

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 321
Study: 19070761

Group type: EXPERIMENTAL
Intervention: Endoscopically assisted open reduction and internal fixation
Number of subjects: 74

Group type: COMPARATOR
Intervention: Nonendoscopic open reduction and internal fixation using an extraoral approach
Number of subjects: 74
Study: 17432641

Group type: EXPERIMENTAL
Intervention: Yang's cotton moxibustion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Triamcinolone and urea cream
Number of subjects: 60
Study: 15333607

Group type: EXPERIMENTAL
Intervention: Misoprostol 200 microg inserted into the posterior fornix of the vagina (Group A, n=72)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Laminaria tents inserted intracervically (Group B, n=72)
Number of subjects: 144
Study: 11448407

Group type: EXPERIMENTAL
Intervention: PTCA
Number of subjects: 891
Study: 9972900

Group type: EXPERIMENTAL
Intervention: Growth factor FGF injected into the myocardium during aortocoronary bypass surgery.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no FGF injection).
Number of subjects: 40
Study: 7919075

Group type: EXPERIMENTAL
Intervention: Nurse-administered health checks
Number of subjects: 8100
Study: 3236382

Group type: EXPERIMENTAL
Intervention: Dog petting
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Talking to the dog
Number of subjects: 60

Group type: COMPARATOR
Intervention: Talking to the experimenter
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Talking to or touching the dog
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Touching and talking to the dog
Number of subjects: 60
Study: 29642075

Group type: EXPERIMENTAL
Intervention: Topical sucralfate gel
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 28532499

Group type: EXPERIMENTAL
Intervention: Laparoscopic mini gastric bypass (LMGB)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 80
Study: 25178692

Group type: EXPERIMENTAL
Intervention: Intravenous amiodarone (300 mg loading dose followed by 15 mg/kg infusion for two days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23565591

Group type: COMPARATOR
Intervention: Intensive advice to withdraw overused medication (Group A)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Standard outpatient detoxification programme (Group B)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Standard inpatient withdrawal programme (Group C)
Number of subjects: 137
Study: 21144093

Group type: EXPERIMENTAL
Intervention: Weight loss intervention group (dietary and exercise programmes)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Weight loss intervention group
Number of subjects: 104

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 104
Study: 18479317

Group type: EXPERIMENTAL
Intervention: Various interventions for depression, schizophrenia, and bipolar disorder; specific interventions and dosages not provided.
Number of subjects: 0
Study: 17209345

Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 24

Group type: COMPARATOR
Intervention: No erythromycin (Control)
Number of subjects: 24
Study: 12538778

Group type: EXPERIMENTAL
Intervention: Former IDA children
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonanemic children
Number of subjects: 0
Study: 10743865

Group type: EXPERIMENTAL
Intervention: 25% metronidazole gel
Number of subjects: 43

Group type: COMPARATOR
Intervention: No gel (control)
Number of subjects: 43
Study: 8752181

Group type: EXPERIMENTAL
Intervention: Scoring system using ST-segment and T-wave changes on ECG (variables: ST-segment elevation in leads V1 to V4 and T-wave negativity in leads I, aVL, and V5)
Number of subjects: 451
Study: 1460163

Group type: EXPERIMENTAL
Intervention: D-fenfluramine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: ECT, fluoxetine, or amitriptyline
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Combined studies
Number of subjects: 21
Study: 6229740

Group type: EXPERIMENTAL
Intervention: 1 g metronidazole suppository, administered 12-hourly starting 48 hours before elective surgery
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 0.5 g metronidazole i.v. over 20 minutes and 1 g suppository at premedication, continued with one suppository 12-hourly
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1 g metronidazole suppository, administered 8-hourly starting 24 hours before surgery for high-risk patients
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Rectal treatment
Number of subjects: 10
Study: 30676094

Group type: EXPERIMENTAL
Intervention: 0.5 mM NAC
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 1 mM NAC
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 5 mM NAC
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 25 mM NAC
Number of subjects: 13

Group type: COMPARATOR
Intervention: 0 mM NAC
Number of subjects: 13
Study: 29579671

Group type: EXPERIMENTAL
Intervention: TRS2˚P risk score
Number of subjects: 9618
Study: 30650291

Group type: COMPARATOR
Intervention: Longbishu Capsule (LBS) placebos combined Doxazosin Mesylate Tablet (DMT)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Longbishu Capsule (LBS) combined Doxazosin Mesylate Tablet (DMT)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Longbishu Capsule (LBS) combined Doxazosin Mesylate Tablet (DMT) placebos
Number of subjects: 360
Study: 24746224

Group type: EXPERIMENTAL
Intervention: Bee venom acupuncture (BVA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Non-steroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined treatment (BVA + NSAIDs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 23172029

Group type: EXPERIMENTAL
Intervention: 6.5 mM fluconazole
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: lidocaine/prilocaine cream
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: fluconazole + lidocaine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 10 mM N(G)‐monomethyl‐l‐arginine (l‐NMMA)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: fluconazole + l‐NMMA
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 20833973

Group type: EXPERIMENTAL
Intervention: Aerobic exercise for 16 weeks
Number of subjects: 319

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 319
Study: 18166301

Group type: EXPERIMENTAL
Intervention: Nonoxynol-9 spermicides
Number of subjects: 151

Group type: COMPARATOR
Intervention: Condom use
Number of subjects: 151
Study: 15878759

Group type: EXPERIMENTAL
Intervention: Accelerated chemotherapy (CT) regimen: 3 cycles of cisplatin and 5-fluorouracil (days 1, 14, and 28) followed by hyperfractionated radiation therapy (RT) (7440 cGy/62 fractions)
Number of subjects: 68
Study: 12560354

Group type: EXPERIMENTAL
Intervention: 400 microg folic acid supplement plus natural diet
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Increased dietary folate to 400 microg/day
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo plus natural diet
Number of subjects: 126
Study: 10622750

Group type: EXPERIMENTAL
Intervention: 100 mL of 25% albumin
Number of subjects: 28

Group type: COMPARATOR
Intervention: Normal saline to increase Pra by 2 mm Hg (n = 15)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Respiratory variation in Pra
Number of subjects: 28
Study: 7791169

Group type: COMPARATOR
Intervention: Indomethacin 150 mg/day (Group A)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Indomethacin 150 mg/day plus misoprostol at 0.6 mg/day (Group B)
Number of subjects: 45
Study: 2289220

Group type: EXPERIMENTAL
Intervention: Tulobuterol 40 micrograms/kg twice daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Albuterol 100 micrograms/kg three times daily
Number of subjects: 40
Study: 7235865

Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy (B group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No follow-up treatment (A group)
Number of subjects: 60
Study: 31255504

Group type: COMPARATOR
Intervention: Haemonetics MCS+
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Terumo Spectra Optia
Number of subjects: 69
Study: 28051319

Group type: EXPERIMENTAL
Intervention: Yoga program (12 weeks, twice a week for 60 minutes, including breathing exercises, yoga pose practice, and supine meditation/relaxation)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no yoga practice, maintain usual physical activity)
Number of subjects: 26
Study: 26301241

Group type: EXPERIMENTAL
Intervention: Signature CT-based implant positioning system
Number of subjects: 112

Group type: COMPARATOR
Intervention: Conventional instrumentation
Number of subjects: 112
Study: 24565021

Group type: EXPERIMENTAL
Intervention: CDSS monitored weaning
Number of subjects: 380

Group type: COMPARATOR
Intervention: Traditional weaning method
Number of subjects: 380
Study: 21372621

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) and Well-Being Therapy (WBT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Clinical Management (CM)
Number of subjects: 62
Study: 18463106

Group type: EXPERIMENTAL
Intervention: Soy protein alone
Number of subjects: 6

Group type: COMPARATOR
Intervention: Meal containing soy protein
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 17133051

Group type: EXPERIMENTAL
Intervention: Medication (n = 19)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Observation (n = 21)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Medication (n = 26)
Number of subjects: 47
Study: 15849961

Group type: EXPERIMENTAL
Intervention: vax-TyVi
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: TYPHIM Vi
Number of subjects: 323

Group type: COMPARATOR
Intervention: vax-TET
Number of subjects: 323
Study: 10972631

Group type: EXPERIMENTAL
Intervention: Immediate simvastatin treatment (40 mg/d)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Deferred simvastatin treatment (40 mg/d after 3 months if LDL-C >3.0 mmol/L)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Both groups (immediate and deferred simvastatin treatment)
Number of subjects: 151
Study: 1574970

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of naloxone 1 microgram kg‐1 h‐1
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 27
Study: 4019017

Group type: EXPERIMENTAL
Intervention: Group D (30 min of daily self‐selected aerobic activity)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Group P (prescribed exercise training performed every other day)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Group C (Control, no exercise program)
Number of subjects: 78
Study: 31320980

Group type: EXPERIMENTAL
Intervention: Antioxidant cocktail (AOC) - 1,000 mg vitamin C, 600 IU vitamin E, and 600 mg α-lipoic acid
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Antioxidant cocktail (AOC)
Number of subjects: 18
Study: 29365309

Group type: EXPERIMENTAL
Intervention: Glecaprevir-Pibrentasvir for 8 weeks
Number of subjects: 1208

Group type: EXPERIMENTAL
Intervention: Glecaprevir-Pibrentasvir for 12 weeks
Number of subjects: 1208

Group type: EXPERIMENTAL
Intervention: Glecaprevir-Pibrentasvir for 12 weeks (Genotype 3)
Number of subjects: 1208

Group type: COMPARATOR
Intervention: Sofosbuvir-Daclatasvir for 12 weeks (Genotype 3)
Number of subjects: 1208

Group type: EXPERIMENTAL
Intervention: Glecaprevir-Pibrentasvir for 8 weeks (Genotype 3)
Number of subjects: 1208
Study: 26352063

Group type: EXPERIMENTAL
Intervention: Low-dose dopamine (3 μg/kg/min)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Medium-dose dopamine (5 μg/kg/min)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no dopamine treatment)
Number of subjects: 60
Study: 25799714

Group type: EXPERIMENTAL
Intervention: Trifecta valve (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Freestyle valve (n = 20)
Number of subjects: 40
Study: 22647932

Group type: EXPERIMENTAL
Intervention: Blurring lenses ranging from -0.50 to +1.50 D in 0.25 D steps
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 0-100 numeric rating scale (NRS)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 100 mm visual analog scale (VAS)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 5 point categorical rating scale (CRS)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All scales (NRS, VAS, CRS)
Number of subjects: 10
Study: 20920275

Group type: EXPERIMENTAL
Intervention: Increase fruits and vegetables and increase physical activity
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Decrease saturated fat and increase physical activity
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Increase fruits and vegetables and decrease saturated fat
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Decrease saturated fat and decrease sedentary activity
Number of subjects: 200
Study: 18606496

Group type: EXPERIMENTAL
Intervention: Functional electrostimulation (FES) in group G36 (n=9)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Functional electrostimulation (FES) in group G24 (n=9)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (n=9)
Number of subjects: 27
Study: 16412324

Group type: EXPERIMENTAL
Intervention: Preeclampsia
Number of subjects: 60
Study: 12131261

Group type: EXPERIMENTAL
Intervention: Reboxetine 2 x 4 mg (REB)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Reboxetine (REB)
Number of subjects: 7
Study: 10421596

Group type: EXPERIMENTAL
Intervention: Ibutilide fumarate 0.25 mg
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Ibutilide fumarate 0.5 mg
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Ibutilide fumarate 1.0 mg
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Ibutilide (all doses)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Ibutilide
Number of subjects: 302
Study: 8678066

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) treatment
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) treatment in elderly patients
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) treatment in younger patients
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (no EPO treatment)
Number of subjects: 57
Study: 1507095

Group type: EXPERIMENTAL
Intervention: Heat-cured polymethylmethacrylate
Number of subjects: 53

Group type: COMPARATOR
Intervention: Autopolymerized polymethylmethacrylate
Number of subjects: 53
Study: 6606554

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 (PGE2)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (four times 0.5 g/d)
Number of subjects: 6

Group type: COMPARATOR
Intervention: No medication
Number of subjects: 6
Study: 31783800

Group type: EXPERIMENTAL
Intervention: NeCR intervention (nurse-led eHealth cardiac rehabilitation)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 146
Study: 29367197

Group type: EXPERIMENTAL
Intervention: Abiraterone
Number of subjects: 202

Group type: COMPARATOR
Intervention: Enzalutamide
Number of subjects: 202
Study: 26589368

Group type: EXPERIMENTAL
Intervention: rosuvastatin (5mg/day)
Number of subjects: 111

Group type: COMPARATOR
Intervention: atorvastatin (10mg/day)
Number of subjects: 111